According to the latest report by IMARC Group, titled, “Beta Glucan Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, the global beta glucan market reached a value of US$ 446.5 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 691.3 Million by 2027, exhibiting at a CAGR of 7.80% during 2022-2027.
Beta glucan is a soluble fiber naturally present in the cell walls of bacteria, yeast, fungi, and some plants. It can provide several health benefits, such as lowering blood cholesterol levels, improving glycemic control, and strengthening the immune system. Consequently, it is widely used in the treatment of heart diseases, hypercholesterolemia, eczema, and diabetes.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/beta-glucan-market/requestsample
The global beta glucan market is primarily driven by the rising prevalence of chronic diseases on account of population aging and sedentary lifestyles. Beta glucan is known to help the body fight certain common illnesses and strengthen the body’s defenses against the harmful effects of stress. As a result, it is widely used in dietary supplements and functional foods. Apart from this, beta glucan is also used in personal care products like shower gels, shaving creams, and toothpaste on account of its soothing and moisturizing properties. The increasing demand for natural and plant-based products among consumers is further projected to propel the market growth.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- American International Chemical LLC (LeBaronBrown Industries LLC)
- Beta Bio Technology Sp Z O O
- Ceapro Inc.
- Garuda International Inc.
- Kemin Industries Inc.
- Kerry Group plc
- Koninklijke DSM N.V.
- Lallemand Inc.
- Super Beta Glucan Inc.
- Tate & Lyle plc
- Van Wankum Ingredients.
The report has segmented the market based on type, source and industry vertical.
Breakup by Type:
Breakup by Source:
Breakup by Industry Vertical:
- Animal Feed
- Personal Care and Cosmetics
Breakup by Region:
- North America
- Latin America
- Middle East and Africa
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/beta-glucan-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800